Venmax Drugs and Pharmaceuticals share consolidation history
BSE: 531015Pharmaceuticals & BiotechnologySmall Cap
Venmax Drugs and Pharmaceuticals Ltd · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1995
Last close ₹14.00up ₹0.13 (0.94%)
Share price at the BSE close on 27 Oct 2026. Previous close ₹13.87.
27 Oct: open ₹15.00, high ₹15.00, low ₹13.40
52-week range of traded prices to 27 Oct 2026
₹12.71Low, 17 Sep 2026₹31.49High, 3 Dec 2025
- Under BSE's graded surveillance, stage 0, on the list for 26 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹16 Cr4,053rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Not shown: another business merged into the company on 30 Jun 2026, and the accounts this figure is made of do not include it yet. It returns once accounts of the company as it now is are filed. Price to book: how it is worked out
- Mergernew accounts awaited
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,586
Venmax Drugs and Pharmaceuticals has made no bonus issue or split since Jan 2007; its other changes to its shares on record are below.
What one share became
None changes what a holding is worth on the day.
- Consolidations
- 1
Share consolidations: face value, ex-date and record date
A share consolidation merges several shares into one of a higher face value. On record from 2007.
Shares today for one held before the ex-date, after every event sinceShares today for one share held before. One share multiplied by the share factor of this bonus or split and of every one after it: a 1:1 bonus doubles the count, and a split of a ₹10 share into ₹2 shares multiplies it by five. Shares today for one share held before in the glossary
- 29 Jan 2009 · ex-dateConsolidation, ratio not statedRecord date 12 Feb 2009Not known